Expanding analyst interest in ORYZON

by Oryzon Genomics

New U.S. investment bank joins, bringing total coverage to ten analysts

Read more

ORYZON receives European Medicines Agency approval to initiate a Phase Ib study of iadademstat in sickle cell disease

by Oryzon Genomics

Oryzon Genomics, a clinical-stage biopharmaceutical company and a European leader in epigenetics, today announced that the European Medicines Agency (EMA) has approved its Clinical Trial Application (...

Read more

Study explains how lymphoma rewires human genome

by Centre for Genomic Regulation

A study published today in Nucleic Acids Research shows a new way translocations promote cancer. The translocation most typically found in mantle cell lymphoma drags a powerful regulatory element into...

Read more

Dos ‘guardianes epigenéticos’ protegen la identidad de las neuronas

by CSIC - Centro Superior de Investigaciones Científicas

Un estudio del Instituto de Neurociencias (CSIC-UMH) muestra en ratones cómo dos enzimas colaboran para evitar que las neuronas activen genes inadecuados y garantizar su correcto funcionamiento

Read more

A new epigenetic methodology makes it possible to reconstruct the evolution of cancer and anticipate its clinical progression

by Fundació Clínic per a la Recerca Biomèdica

The research team discovered that the original cell that gave rise to the tumour leaves a unique methylation signature, a fingerprint that not only reveals the identity of the tumour cells, but also c...

Read more

ORYZON strengthens patent portfolio for iadademstat and vafidemstat with new Decisions to Grant

by Oryzon Genomics

Oryzon Genomics, S.A. a clinical-stage biopharmaceutical company and a European leader in epigenetics, today announced that it continues to expand its patent portfolio for iadademstat and vafidemstat,...

Read more

ORYZON strengthens patent portfolio for iadademstat with European grant decision covering combinations with PD1/PD-L1 inhibitors

by Oryzon Genomics

Oryzon Genomics today announced that the European Patent Office (EPO) has issued a Decision to Grant for its patent application EP20712594.9, entitled “Combinations of iadademstat for cancer therapy...

Read more

A study led by SJD identifies new therapeutic targets for Ewing sarcomade Ewing

by Hospital Sant Joan de Déu

An international team led by the Institut de Recerca Sant Joan de Déu (IRSJD), the Pediatric Cancer Center Barcelona of the SJD Barcelona Children’s Hospital, and the Centre for Genomic Regulation ...

Read more

Integrated DNA Technologies and Profluent Collaborate to Unlock New Frontier of AI-driven Protein Design

by Integrated DNA Technologies

From model to molecule: Partnership combines pioneering AI for protein design with genomics expertise to accelerate development of next generation enzymes

Read more

Identifican 'relojes epigenéticos' que predicen el envejecimiento y riesgo de enfermedades en personas con VIH controlado

by Professional Newco

El trabajo, publicado en la revista Clinical Infectious Diseases, analiza el valor pronóstico de los llamados “relojes epigenéticos”, indicadores biológicos capaces de estimar la edad biológic...

Read more

Descubren señales moleculares en el ADN que explican la inflamación crónica de las arterias a partir de los 50 años

by CSIC - Centro Superior de Investigaciones Científicas

El estudio identifica también células inmunitarias 'agotadas' que podrían explicar por qué la inflamación persiste en la enfermedad denominada arteritis de células gigantes

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream